BACKGROUND: The nuclear transcription factor NF-κB has gained considerable importance due to its major involvement in inflammation and constitutive activity in malignant cells. It is induced by a variety of stimuli and controls the expression of several proteins involved in biological processes. Numerous natural products and synthesized organic molecules have been reported to inhibit NF-κB and have played an integral role in identifying implicated pathways. Prominent among them are the sesquiterpene lactones, polyphenolic enones and other α,β-unsaturated carbonyl-containing molecules, particularly α-methylene-γ-butyrolactones. DISCUSSION: This mini-review provides an introductory overview of some of the associated pathways involving NF-κB in cancer and discusses the structures and mode of action of natural α,β-unsaturated carbonyl-containing inhibitors and their synthetic counterparts. A review of the recent methods for the synthesis of α-alkylidene-γ-butyrolactones is also provided, with the aim of arousing the interest of synthetic chemists for the design and development of novel NF-κB inhibitors. CONCLUSIONS: Modulating damaging effects without harming the inflammatory and immune responses are crucial parameters for developing NF-κB inhibitors. Examination of novel α,β-unsaturated carbonyls and the further discovery of simple methods to prepare such molecules should lead to the identification of site-specific inhibitors.
BACKGROUND: The nuclear transcription factor NF-κB has gained considerable importance due to its major involvement in inflammation and constitutive activity in malignant cells. It is induced by a variety of stimuli and controls the expression of several proteins involved in biological processes. Numerous natural products and synthesized organic molecules have been reported to inhibit NF-κB and have played an integral role in identifying implicated pathways. Prominent among them are the sesquiterpene lactones, polyphenolic enones and other α,β-unsaturated carbonyl-containing molecules, particularly α-methylene-γ-butyrolactones. DISCUSSION: This mini-review provides an introductory overview of some of the associated pathways involving NF-κB in cancer and discusses the structures and mode of action of natural α,β-unsaturated carbonyl-containing inhibitors and their synthetic counterparts. A review of the recent methods for the synthesis of α-alkylidene-γ-butyrolactones is also provided, with the aim of arousing the interest of synthetic chemists for the design and development of novel NF-κB inhibitors. CONCLUSIONS: Modulating damaging effects without harming the inflammatory and immune responses are crucial parameters for developing NF-κB inhibitors. Examination of novel α,β-unsaturated carbonyls and the further discovery of simple methods to prepare such molecules should lead to the identification of site-specific inhibitors.
Authors: Bryan K Holcomb; Michele T Yip-Schneider; Joshua A Waters; Joal D Beane; Peter A Crooks; C Max Schmidt Journal: J Gastrointest Surg Date: 2012-05-23 Impact factor: 3.452
Authors: Sandeep Rana; Elizabeth C Blowers; Calvin Tebbe; Jacob I Contreras; Prakash Radhakrishnan; Smitha Kizhake; Tian Zhou; Rajkumar N Rajule; Jamie L Arnst; Adnan R Munkarah; Ramandeep Rattan; Amarnath Natarajan Journal: J Med Chem Date: 2016-04-26 Impact factor: 7.446
Authors: Ritu Arora; Clayton Yates; Bernard D Gary; Steven McClellan; Ming Tan; Yaguang Xi; Eddie Reed; Gary A Piazza; Laurie B Owen; Windy Dean-Colomb Journal: PLoS One Date: 2014-06-04 Impact factor: 3.240